Challenges in evaluation and reimbursement of drugs for rare diseases in Saudi Arabia: a Delphi expert consensus

This study provides the first consensus on challenges in DRD evaluation and reimbursement in Saudi Arabia. Addressing these issues through policy reforms, stakeholder collaboration, and data infrastructure enhancement is crucial to optimising resource allocation and patient access. Further research should focus on implementing value-based agreement to ensure sustainable reimbursement strategies for DRDs.

Authors

Institutions

Publication Details

Journal
Journal of Pharmaceutical Policy and Practice
Published
2025-10-28
DOI
https://doi.org/10.1080/20523211.2025.2575040
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Challenges in evaluation and reimbursement of drugs for rare diseases in Saudi Arabia: a Delphi expert consensus

Roaa Al Gain, Mohamed Ahmed Mpharm, Aljawharah Alkoraishi, Hend Metwali et al.
Journal of Pharmaceutical Policy and Practice
Genomics and Rare Diseases
article

Challenges in evaluation and reimbursement of drugs for rare diseases in Saudi Arabia: a Delphi expert consensus

Roaa Al Gain, Mohamed Ahmed Mpharm, Aljawharah Alkoraishi, Hend Metwali, Sakra Balhareth, Mansoor Ahmed Khan, Abdullah Alhammad, Ziyad S. Almalki, Laila Carolina Abu Esba, Esraa Altawil, Amal Hassan Al-Najjar, Fatma Maraiki, Consuela Cheriece Yousef, Hussain Abdulrahman Al‐Omar, Hind Almodaimegh, Abdulaziz Alhossan, Mohammed Al Harbi, Layla Al Anizy, Abdulrazaq Al Jazairi
article en

Abstract

This study provides the first consensus on challenges in DRD evaluation and reimbursement in Saudi Arabia. Addressing these issues through policy reforms, stakeholder collaboration, and data infrastructure enhancement is crucial to optimising resource allocation and patient access. Further research should focus on implementing value-based agreement to ensure sustainable reimbursement strategies for DRDs.

Journal of Pharmaceutical Policy and PracticeVol. 18(1)
Prince Sattam Bin Abdulaziz University (SA), King Saud bin Abdulaziz University for Health Sciences (SA), King Faisal Specialist Hospital & Research Centre (SA), King Saud Medical City (SA), Ministero della Salute (IT), King Fahd Medical City (SA), King Saud University (SA), King Abdulaziz Medical City (SA), King Abdullah International Medical Research Center (SA), Imam Abdulrahman Al Faisal Hospital (SA), Ministry of Health (SA), National Guard Health Affairs (SA)
Openalex Percentile: Top 67%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.